What did randomized, double-blind clinical trials of cannabidiol in schizophrenia find?

By Rajnish Mago, MD (bio) On another page on this website, I noted that to evaluate the possible use of cannabidiol as a potential treatment for schizophrenia and other psychotic disorders we can look at several different types of data. On this page, let’s look (chronologically) at the most important source of data for us as…